CytoDyn Inc (CYDY)
0.1470
0.00 (0.00%)
USD |
OTCM |
May 13, 16:00
CytoDyn Enterprise Value: 174.83M for May 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 13, 2024 | 174.83M |
| May 10, 2024 | 173.40M |
| May 09, 2024 | 172.80M |
| May 08, 2024 | 182.13M |
| May 07, 2024 | 175.39M |
| May 06, 2024 | 178.76M |
| May 03, 2024 | 174.79M |
| May 02, 2024 | 166.84M |
| May 01, 2024 | 163.47M |
| April 30, 2024 | 167.80M |
| April 29, 2024 | 166.05M |
| April 26, 2024 | 170.82M |
| April 25, 2024 | 173.80M |
| April 24, 2024 | 176.28M |
| April 23, 2024 | 177.77M |
| April 22, 2024 | 177.87M |
| April 19, 2024 | 182.74M |
| April 18, 2024 | 178.61M |
| April 17, 2024 | 173.80M |
| April 16, 2024 | 175.78M |
| April 15, 2024 | 172.80M |
| April 12, 2024 | 184.72M |
| April 11, 2024 | 186.21M |
| April 10, 2024 | 186.81M |
| April 09, 2024 | 186.21M |
| Date | Value |
|---|---|
| April 08, 2024 | 194.66M |
| April 05, 2024 | 193.71M |
| April 04, 2024 | 187.90M |
| April 03, 2024 | 187.50M |
| April 02, 2024 | 184.20M |
| April 01, 2024 | 192.12M |
| March 28, 2024 | 189.18M |
| March 27, 2024 | 192.47M |
| March 26, 2024 | 190.90M |
| March 25, 2024 | 193.85M |
| March 22, 2024 | 189.33M |
| March 21, 2024 | 189.43M |
| March 20, 2024 | 187.75M |
| March 19, 2024 | 197.05M |
| March 18, 2024 | 194.08M |
| March 15, 2024 | 194.02M |
| March 14, 2024 | 194.58M |
| March 13, 2024 | 202.99M |
| March 12, 2024 | 202.00M |
| March 11, 2024 | 211.70M |
| March 08, 2024 | 214.91M |
| March 07, 2024 | 207.94M |
| March 06, 2024 | 222.79M |
| March 05, 2024 | 226.85M |
| March 04, 2024 | 276.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
116.12M
Minimum
Nov 29 2019
4.559B
Maximum
Jun 29 2020
793.22M
Average
367.45M
Median
Oct 03 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.386M |
| Palatin Technologies Inc | 29.73M |
| iBio Inc | 16.19M |
| Theriva Biologics Inc | -8.842M |
| Oragenics Inc | 5.143M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.92M |
| Total Expenses (Quarterly) | 3.414M |
| EPS Diluted (Quarterly) | -0.01 |
| Earnings Yield | -34.00% |